NCT05060783View on ClinicalTrials.gov

Renal Cancer Detection With Liquid Biopsy

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2027

Conditions
Renal CancerOncocytoma
Interventions
DIAGNOSTIC_TEST

GaGnostic

Plasma

DIAGNOSTIC_TEST

GaGnostic

Serum

DIAGNOSTIC_TEST

GaGnostic

Urine

Trial Locations (1)

4000

RECRUITING

Zealand University Hospital, Roskilde

Sponsors

Collaborators (1)

Elypta
All Listed Sponsors
collaborator

Lund University

OTHER

collaborator

Elypta

INDUSTRY

lead

Zealand University Hospital

OTHER

NCT05060783 - Renal Cancer Detection With Liquid Biopsy | Biotech Hunter | Biotech Hunter